Calypso taps Vertatschitsch as CEO

Clint vanSonnenberg | | Health Imaging | Artificial Intelligence
Calypso Medical Technologies has named Edward Vertatschitsch, PhD, as the company's president and CEO.

Vertatschitsch, who has served as executive vice president of operations as well as research and development, and is currently interim CEO, has worked with Calypso for seven years. Previously, Vertatschitsch managed hardware development at Palm, where he managed the development of the PDA, after serving as chief scientist at Boeing.

Vertatschitsch earned his PhD in electrical engineering from McMaster University in Ontario. Calypso develops real-time localization technology for tumor-tracking and is headquartered in Seattle.

Clint vanSonnenberg

Related Content

Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Radiomics model links brain MRI features with neuropsychological changes in Crohn's disease
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Routine abdominal CTs offer insight into cardiovascular risk
Up to half of medical organizations either already using or preparing to implement AI
Philips, Mayo Clinic using AI to improve cardiac MRI technology

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.